Apollo Endosurgery, Inc. (APEN)
(Delayed Data from NSDQ)
$3.54 USD
-0.28 (-7.33%)
Updated May 3, 2019 04:13 PM ET
After-Market: $3.95 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[APEN]
Reports for Purchase
Showing records 1 - 20 ( 29 total )
Industry: Medical - Instruments
Industry: Medical - Instruments
We are dropping coverage due to the departure of the covering analyst
Provider: Roth Capital Partners, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Instruments
Industry: Medical - Instruments
Healthcare - Medical Technology: Key Takeaways From Obesity Week on U.S. Balloon Market
Provider: Roth Capital Partners, Inc.
Analyst: SOLOMON D
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Instruments
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Biomedical and Genetics
Takeaways from DDW and OverStitch Mobile Training Lab
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Biomedical and Genetics
FDA Updates Orbera Safety - Within Expectations, but Not Great Press
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Biomedical and Genetics
1Q18 Recap - Key EndoBariatric Segment on Track
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Biomedical and Genetics
4Q17 Recap - Endobariatric Growth Driving Upside to Revenue Outlook
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.